Capacity of macrophages to produce reactive oxygen intermediates - Deactivation by transforming growth factor-.BETA..:<I>deactivation by transforming growth factor-β</I>
スポンサーリンク
概要
- 論文の詳細を見る
On inflammatory initiation, macrophages are enhanced in their capacity to produce reactive oxygen intermediates such as O<SUP>-</SUP><SUB>2</SUB> and H<SUB>2</SUB>O<SUB>2</SUB>, and kill microbes for host survival from infection. Contrary to the initiation, the mechanism to cease inflammation is hardly understood. Since permanent producing of reactive oxygen intermediates is toxic, the host itself probably requires the ability to deactivate macrophages. Macrophages are essential to the healing of wounds and repair of tissue damaged by inflammation. These concepts led us to search for macrophage deactivating effects among polypeptide growth factors that regulate angiogenesis, fibrogenesis and other aspects of tissue repair. Among 12 such factors, two polypeptides that possess 71% similar homology proved to be potent macrophage deactivators: transforming growth factor-β1 (TGF-β1) and TGF-β2.<BR>The fact that their concentrations for 50% inhibition were extremely low of picomolar level, suggests TGF-β play a powerful role on ceasing the inflammation and tissue repair after an inflammation site has been sterilized. Although the deactivating site by TGF-β existed in anabolism but nct catabolism of reactive oxygen intermediates, exact site is not yet determined.
- 日本炎症・再生医学会の論文
日本炎症・再生医学会 | 論文
- 新規キノリノン誘導体TA-270の炎症性気道疾患に対する効果
- Salazosulphapyridine, Predonizolone の好中球機能に及ぼす影響と Sodium ferrous citrate との併用効果についての検討
- Sodium ferrous citrate の好中球機能に及ぼす影響
- Mesalazine(Pentasa) の好中球機能に及ぼす影響と Sodium ferrous citrate(SFC) との併用効果についての検討
- 非ウイルスベクターによる細胞標的法の開発